Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
29.23
-0.89 (-2.95%)
Mar 31, 2025, 9:47 AM EDT - Market open
Company Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally.
The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis.
It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008.
Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Veracyte, Inc.
| Country | United States |
| Founded | 2006 |
| IPO Date | Oct 30, 2013 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 824 |
| CEO | Marc Stapley |
Contact Details
Address: 6000 Shoreline Court, Suite 300 South San Francisco, California 94080 United States | |
| Phone | 650 243 6300 |
| Website | veracyte.com |
Stock Details
| Ticker Symbol | VCYT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001384101 |
| CUSIP Number | 92337F107 |
| ISIN Number | US92337F1075 |
| Employer ID | 20-5455398 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Marc A. Stapley | Chief Executive Officer and Director |
| Rebecca Chambers | Executive Vice President and Chief Financial Officer |
| Dr. Phillip G. Febbo M.D. | Chief Scientific and Medical Officer |
| Annie McGuire | Executive Vice President, General Counsel and Chief People Officer |
| Dr. John Leite Ph.D. | Chief Commercial Officer |
| Dr. Keith Gligorich Ph.D. | Senior Vice President of Global Operations |
| Jonathan Wygant | Vice President and Chief Accounting Officer |
| Steven French | Senior Vice President and Chief Information Officer |
| Karen Possemato | Senior Vice President of Corporate Marketing, Communications and Commercial Operations |
| Robert Brainin | Executive Vice President and Chief Business Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 7, 2025 | 144 | Filing |
| Mar 4, 2025 | 144 | Filing |
| Mar 4, 2025 | 144 | Filing |
| Mar 4, 2025 | 144 | Filing |
| Feb 28, 2025 | 10-K | Annual Report |
| Feb 24, 2025 | 8-K | Current Report |
| Feb 12, 2025 | SCHEDULE 13G/A | Filing |
| Jan 10, 2025 | SCHEDULE 13G/A | Filing |
| Jan 2, 2025 | 144 | Filing |
| Dec 13, 2024 | 144 | Filing |